Efficacy and safety of 3‐month dosing regimen of degarelix in Japanese subjects with prostate cancer: A phase III study

JOURNAL ARTICLE published June 2018 in Cancer Science

Authors: Seiichiro Ozono | Taiji Tsukamoto | Seiji Naito | Shigeo Horie | Yasuo Ohashi | Hiroji Uemura | Yumiko Yokomizo | Satoshi Fukasawa | Hidehito Kusuoka | Rio Akazawa | Masako Saito | Hideyuki Akaza